Rika Maruyama

2.1k total citations · 1 hit paper
58 papers, 1.5k citations indexed

About

Rika Maruyama is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Rika Maruyama has authored 58 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 13 papers in Genetics and 11 papers in Surgery. Recurrent topics in Rika Maruyama's work include Muscle Physiology and Disorders (26 papers), Neurogenetic and Muscular Disorders Research (11 papers) and Tissue Engineering and Regenerative Medicine (9 papers). Rika Maruyama is often cited by papers focused on Muscle Physiology and Disorders (26 papers), Neurogenetic and Muscular Disorders Research (11 papers) and Tissue Engineering and Regenerative Medicine (9 papers). Rika Maruyama collaborates with scholars based in Canada, Japan and United States. Rika Maruyama's co-authors include Toshifumi Yokota, Kenji Rowel Q. Lim, Yusuke Echigoya, Deborah J. Andrew, Yoshitsugu Aoki, Toshifumi Yokota, Shin’ichi Takeda, William Duddy, Akinori Nakamura and Asako Sugimoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Rika Maruyama

56 papers receiving 1.5k citations

Hit Papers

Eteplirsen in the treatment of Duchenne muscular dystrophy 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Eteplirsen in the treatment of Duchenne muscular dystrophy
    2017 361 citations Kenji Rowel Q. Lim, Rika Maruyama et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rika Maruyama Canada 22 1.3k 231 209 152 125 58 1.5k
Stéphanie Lorain France 18 1.6k 1.3× 126 0.5× 366 1.8× 200 1.3× 28 0.2× 32 1.9k
Bennett H. Penn United States 9 1.5k 1.2× 67 0.3× 262 1.3× 72 0.5× 30 0.2× 12 1.6k
Caroline Godfrey United Kingdom 16 1.5k 1.2× 209 0.9× 192 0.9× 162 1.1× 13 0.1× 24 1.6k
Graham McClorey United Kingdom 24 1.7k 1.4× 243 1.1× 353 1.7× 204 1.3× 15 0.1× 41 1.8k
J. van Deutekom Netherlands 12 904 0.7× 212 0.9× 338 1.6× 179 1.2× 21 0.2× 25 1.1k
Davide Gabellini Italy 22 1.6k 1.3× 232 1.0× 243 1.2× 192 1.3× 13 0.1× 46 1.8k
Colin Crist Canada 14 1.1k 0.9× 120 0.5× 89 0.4× 34 0.2× 67 0.5× 24 1.2k
Steve J. Winder United Kingdom 23 1.2k 0.9× 78 0.3× 87 0.4× 119 0.8× 30 0.2× 51 1.5k
Dina A. Faddah United States 9 1.9k 1.5× 35 0.2× 180 0.9× 26 0.2× 79 0.6× 12 2.0k

Countries citing papers authored by Rika Maruyama

Since Specialization
Citations

This map shows the geographic impact of Rika Maruyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rika Maruyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rika Maruyama more than expected).

Fields of papers citing papers by Rika Maruyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rika Maruyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rika Maruyama. The network helps show where Rika Maruyama may publish in the future.

Co-authorship network of co-authors of Rika Maruyama

This figure shows the co-authorship network connecting the top 25 collaborators of Rika Maruyama. A scholar is included among the top collaborators of Rika Maruyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rika Maruyama. Rika Maruyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Powell, Barry C., Pavel Zhabyeyev, Saeed Anwar, et al.. (2025). DG9 boosts PMO nuclear uptake and exon skipping to restore dystrophic muscle and cardiac function. Nature Communications. 16(1). 4477–4477. 1 indexed citations
2.
Kim, Ji Hoon, et al.. (2025). Arc controls organ architecture through modulation of Crb and MyoII. The Journal of Cell Biology. 224(9). 1 indexed citations
3.
4.
5.
Ren, Jun, Kenji Rowel Q. Lim, Hong M. Moulton, et al.. (2023). DG9-conjugated morpholino rescues phenotype in SMA mice by reaching the CNS via a subcutaneous administration. JCI Insight. 8(5). 10 indexed citations
6.
7.
8.
Mamchaoui, Kamel, M.K. Tsoumpra, Rika Maruyama, et al.. (2021). Immortalized Canine Dystrophic Myoblast Cell Lines for Development of Peptide-Conjugated Splice-Switching Oligonucleotides. Nucleic Acid Therapeutics. 31(2). 172–181. 10 indexed citations
9.
Lim, Kenji Rowel Q., Rika Maruyama, Yusuke Echigoya, et al.. (2020). Inhibition of DUX4 expression with antisense LNA gapmers as a therapy for facioscapulohumeral muscular dystrophy. Proceedings of the National Academy of Sciences. 117(28). 16509–16515. 43 indexed citations
10.
Bittel, Adam J., Sen Chandra Sreetama, Daniel C. Bittel, et al.. (2020). Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy. International Journal of Molecular Sciences. 21(15). 5575–5575. 21 indexed citations
11.
Maruyama, Rika, et al.. (2018). Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts. Journal of Visualized Experiments. 4 indexed citations
12.
Maruyama, Rika & Toshifumi Yokota. (2018). Morpholino-Mediated Exon Skipping Targeting Human ACVR1/ALK2 for Fibrodysplasia Ossificans Progressiva. Methods in molecular biology. 1828. 497–502. 4 indexed citations
13.
Maruyama, Rika, et al.. (2018). Systemic Injection of Peptide-PMOs into Humanized DMD Mice and Evaluation by RT-PCR and ELISA. Methods in molecular biology. 1828. 263–273. 3 indexed citations
14.
Lim, Kenji Rowel Q., Yusuke Echigoya, Tetsuya Nagata, et al.. (2018). Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates. Molecular Therapy. 27(1). 76–86. 23 indexed citations
15.
16.
Nakamura, Akinori, Naoko Shiba, Daigo Miyazaki, et al.. (2016). Comparison of the phenotypes of patients harboring in-frame deletions starting at exon 45 in the Duchenne muscular dystrophy gene indicates potential for the development of exon skipping therapy. Journal of Human Genetics. 62(4). 459–463. 53 indexed citations
17.
Echigoya, Yusuke, et al.. (2016). Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA/2 background. Scientific Reports. 6(1). 38371–38371. 39 indexed citations
18.
Kubota, Yukihiko, et al.. (2014). The PAF1 complex is involved in embryonic epidermal morphogenesis in Caenorhabditis elegans. Developmental Biology. 391(1). 43–53. 9 indexed citations
19.
20.
Maruyama, Rika, Scott M. Gordon, Pavan Kadandale, et al.. (2007). EGG-3 Regulates Cell-Surface and Cortex Rearrangements during Egg Activation in Caenorhabditis elegans. Current Biology. 17(18). 1555–1560. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stéphanie Lorain Breakdown of academic impact, for papers by Bennett H. Penn Breakdown of academic impact, for papers by Caroline Godfrey Breakdown of academic impact, for papers by Graham McClorey Breakdown of academic impact, for papers by J. van Deutekom Breakdown of academic impact, for papers by Davide Gabellini Breakdown of academic impact, for papers by Colin Crist Breakdown of academic impact, for papers by Steve J. Winder Breakdown of academic impact, for papers by Dina A. Faddah
Rankless by CCL
2026